The FDA has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta.

Opioid-related neurocognitive symptoms among patients on long-term opioid therapy were most prevalent during the course of therapy.

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for older adults and people with disabilities.

Dexamethasone reduced mortality among patients hospitalized with COVID-19, especially those who were also receiving respiratory support.

President Trump has ended a Biden administration effort to lower the cost of prescription drugs for people on Medicare and Medicaid.

On a global scale, childhood maltreatment is associated with a higher risk for developing some immune-mediated inflammatory disorders.

Efforts to limit access to the abortion drug mifepristone have received a boost from a federal judge who took the bench during President Donald Trump's first term.

The US Department of HHS is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to protect against bird flu.

CGM traces added to DCCT data can predict microvascular diabetes complications similarly to glycated hemoglobin.

Time-restricted eating may not add additional benefit in visceral adipose tissue reduction over the Mediterranean diet for people with overweight or obesity.

Paxlovid may offer marginal benefits for low-risk children with COVID-19; however, among high-risk children with COVID-19, Paxlovid is a safe oral option.

From 1999 to 2019, hyperlipidemia-related CVD mortality increased in the United States, with elderly, Black, rural men being most affected.